Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rocket Doctor AIAIRDF +7.59%27 Cash Ratio is 1.54 as of Mar. 2026, which is 40% above its 10-year median of 1.10. GuruFocus rates AIRDF with a GF Score™ of 27/100. The stock has 7 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Rocket Doctor AI ranks better than 74.25% on this metric.
Rocket Doctor AI has a Cash Ratio of 1.54. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for Rocket Doctor AI's Cash Ratio or its related term are showing as below:
AIRDF'
s Cash Ratio Range Over the Past 10 Years
Min: 0.02 Med: 1.1 Max: 6.08
Current: 1.54
During the past 7 years, Rocket Doctor AI's highest Cash Ratio was 6.08. The lowest was 0.02. And the median was 1.10.
AIRDF's Cash Ratio is ranked better than 74.25% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 0.59
vs AIRDF: 1.54
Rocket Doctor AI (OTCPK:AIRDF) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Rocket Doctor AI Cash Ratio Related Terms
Rocket Doctor AI Cash Ratio Historical Data
* Premium members only.
The historical data trend for Rocket Doctor AI's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Rocket Doctor AI's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rocket Doctor AI Cash Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rocket Doctor AI's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Rocket Doctor AI's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rocket Doctor AI (AIRDF) has a Cash Ratio of 1.54 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Rocket Doctor AI and its competitors. This is 40% above median its historical median of 1.10. Over the past decade, Rocket Doctor AI's Cash Ratio has ranged from 0.02 to 6.08. According to the industry distribution chart, Rocket Doctor AI ranks #171 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 25.8%.
Is Rocket Doctor AI's Cash Ratio too high?
Rocket Doctor AI's current Cash Ratio of 1.54 is 40% above median its 10-year median of 1.10. Over the past 10 years, this metric has ranged from a low of 0.02 to a high of 6.08. The Healthcare Providers & Services industry median Cash Ratio is 0.59. Rocket Doctor AI's value of 1.54 is 161% above this industry median. Based on the distribution chart, Rocket Doctor AI ranks #171 out of 664 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Rocket Doctor AI has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Rocket Doctor AI's Cash Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Rocket Doctor AI ranks #171 out of 664 companies for Cash Ratio. This puts Rocket Doctor AI in the upper half of its industry. The industry median Cash Ratio is 0.59. Rocket Doctor AI's value of 1.54 is 161% above this benchmark. Historically, Rocket Doctor AI's own Cash Ratio has ranged from 0.02 to 6.08 over the past decade. While the company's 10-year median is 1.10 vs. the industry median of 0.59, Rocket Doctor AI has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Healthcare Providers & Services company?
The median Cash Ratio among Healthcare Providers & Services companies is 0.59, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rocket Doctor AI's current Cash Ratio of 1.54 is 161% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Rocket Doctor AI and its competitors. For the Healthcare Providers & Services industry, the median Cash Ratio is 0.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rocket Doctor AI's current Cash Ratio is 1.54, which is 40% above median its own 10-year median of 1.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rocket Doctor AI stock overvalued right now?
Rocket Doctor AI (AIRDF) has a current Cash Ratio of 1.54. The current Cash Ratio is 1.54, which is 40% above median its 10-year median of 1.10 and 161% above the Healthcare Providers & Services industry median of 0.59. Rocket Doctor AI's overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Rocket Doctor AI (AIRDF), the current Cash Ratio is 1.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Rocket Doctor AI Inc delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company's proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians world-wide. Alongside the GLM and its AI-powered digital health platform and marketplace. The group empowers over 300 MDs to provide care to more than 700,000 patients. Its proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.
27GF Score
Get the complete analysis for AIRDF
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIRDF has been successfully added to your 
